SAFEZONE Celebrates 13th Anniversary & Big Wins

SAFEZONE is celebrating its 13th anniversary and some of its big wins in healthcare solutions, including the latest in overcoming COVID.

Having commemorated 13 WONDERFULL, SUCCESSFULL years in business, SAFEZONE, Inc. now reaches a milestone for the VIRGINIA-based HEALTHCARE SOLUTIONS business, providing HEALTHCARE SOLUTIONS to COVID, fitness for the elderly, instructions for schools, educational institutions, corporations, and government agencies since 2007.

SAFEZONE, Inc. got its start in 2007 when founder Krishna Grandhi, one of the family members passed away because of Early COVID days and that made its CEO invent the company’s pandemic contact tracing solution with authentic health vitals.

One of the earliest challenges SAFEZONE faced was developing the technology of contact tracing with authentic information on health vitals when there were no other devices with temperature and oximeter readings in 2019.

Only SafeZone, Inc. customized the sensors in accordance with the demand for them.

While every business must face challenges, some like SAFEZONE are fortunate to enjoy truly successful wins and victories over these 13 blessed years.

Victory came when SAFEZONE was first to implement its Covid solution on Carnival Cruise Liners to protect and prevent passengers before they boarded the ships and also protecting students and teachers at many universities, UONV and schools in various states in the country.

Today dozens of Corporations use SAFEZONE device to stop the spread of the virus even after vaccinations, knowing prevention is better than consequence, so they’re also using the device to contact trace their employees in case of virus symptoms detection.

Brain F, VP of Sales at SAFEZONE, Inc. was also quoted when discussing another big win. “One of the high points of SAFEZONE’s history so far was moving into full health care solution via continuous monitoring of EKG and Blood Sugar using our FDA approved platform.”

SAFEZONE Inc’s Founder, Krishna Grandhi says, “We’re delighted to be celebrating our 13 Year Anniversary. I believe the secret to getting this far in business today is unique solution that doesn’t exist anywhere in the world.”

SAFEZONE Inc currently consists of 30 employees and has big plans for the upcoming year. One of its core objectives is to Help Communities with innovative solutions that do not exist in the world.

SAFEZONE thanks their friends, customers and all its partners for their well wishes on this happy occasion.

Hot this week

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.